Ro CEO Zachariah Reitano at the Financial Times' US Pharma and Biotech Summit (Sarah Merians Photography for Endpoints News)
December 4, 2024 08:00 AM ESTUpdated 09:31 AM
Startups
Pharma
Health Tech

Ro’s weight loss busi­ness more than dou­bled in the last year. Now it’s try­ing to prove its pro­gram works

Shelby Livingston

Senior health tech reporter

With di­rect-to-pa­tient ser­vices for obe­si­ty drugs fac­ing scruti­ny, the tele­health start­up Ro is try­ing to prove that its on­line weight loss pro­gram …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Scott Got­tlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this coun­try’

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

A service from the Financial Times